nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A8—choroid plexus—malignant glioma	0.105	0.634	CbGeAlD
Famotidine—Tonic-clonic seizures—Carmustine—malignant glioma	0.0474	0.0621	CcSEcCtD
Famotidine—Grand mal convulsion—Carmustine—malignant glioma	0.0268	0.0351	CcSEcCtD
Famotidine—Interstitial pneumonia—Temozolomide—malignant glioma	0.0255	0.0334	CcSEcCtD
Famotidine—Interstitial lung disease—Carmustine—malignant glioma	0.018	0.0236	CcSEcCtD
Famotidine—Interstitial lung disease—Temozolomide—malignant glioma	0.0174	0.0228	CcSEcCtD
Famotidine—Extravasation—Carmustine—malignant glioma	0.0146	0.0192	CcSEcCtD
Famotidine—Viral infection—Temozolomide—malignant glioma	0.0137	0.0179	CcSEcCtD
Famotidine—Neck pain—Carmustine—malignant glioma	0.0129	0.0169	CcSEcCtD
Famotidine—Musculoskeletal pain—Temozolomide—malignant glioma	0.0125	0.0163	CcSEcCtD
Famotidine—Influenza like illness—Temozolomide—malignant glioma	0.012	0.0157	CcSEcCtD
Famotidine—Gynaecomastia—Carmustine—malignant glioma	0.0114	0.015	CcSEcCtD
Famotidine—SLC47A1—brainstem—malignant glioma	0.0108	0.0655	CbGeAlD
Famotidine—Swelling—Carmustine—malignant glioma	0.0105	0.0138	CcSEcCtD
Famotidine—Ear pain—Temozolomide—malignant glioma	0.0105	0.0137	CcSEcCtD
Famotidine—Nasal congestion—Temozolomide—malignant glioma	0.00984	0.0129	CcSEcCtD
Famotidine—Face oedema—Carmustine—malignant glioma	0.00895	0.0117	CcSEcCtD
Famotidine—Face oedema—Temozolomide—malignant glioma	0.00865	0.0113	CcSEcCtD
Famotidine—Dry skin—Temozolomide—malignant glioma	0.00821	0.0107	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00807	0.0106	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00807	0.0106	CcSEcCtD
Famotidine—Pancytopenia—Carmustine—malignant glioma	0.00761	0.00996	CcSEcCtD
Famotidine—SLC47A1—medulla oblongata—malignant glioma	0.00755	0.0457	CbGeAlD
Famotidine—Neutropenia—Carmustine—malignant glioma	0.00749	0.0098	CcSEcCtD
Famotidine—Bronchitis—Temozolomide—malignant glioma	0.00745	0.00974	CcSEcCtD
Famotidine—Pancytopenia—Temozolomide—malignant glioma	0.00735	0.00962	CcSEcCtD
Famotidine—Dysuria—Temozolomide—malignant glioma	0.00724	0.00947	CcSEcCtD
Famotidine—Neutropenia—Temozolomide—malignant glioma	0.00724	0.00947	CcSEcCtD
Famotidine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0072	0.00942	CcSEcCtD
Famotidine—Pollakiuria—Temozolomide—malignant glioma	0.00715	0.00936	CcSEcCtD
Famotidine—Erectile dysfunction—Temozolomide—malignant glioma	0.00713	0.00933	CcSEcCtD
Famotidine—Depression—Carmustine—malignant glioma	0.00712	0.00932	CcSEcCtD
Famotidine—HRH2—central nervous system—malignant glioma	0.00708	0.0428	CbGeAlD
Famotidine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00707	0.00925	CcSEcCtD
Famotidine—Depression—Temozolomide—malignant glioma	0.00689	0.00901	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00685	0.00896	CcSEcCtD
Famotidine—SLC47A1—spinal cord—malignant glioma	0.00674	0.0407	CbGeAlD
Famotidine—Sinusitis—Temozolomide—malignant glioma	0.00648	0.00848	CcSEcCtD
Famotidine—Hallucination—Carmustine—malignant glioma	0.00638	0.00835	CcSEcCtD
Famotidine—Hepatitis—Temozolomide—malignant glioma	0.0062	0.00811	CcSEcCtD
Famotidine—Hallucination—Temozolomide—malignant glioma	0.00617	0.00807	CcSEcCtD
Famotidine—Pharyngitis—Temozolomide—malignant glioma	0.00615	0.00805	CcSEcCtD
Famotidine—Flushing—Carmustine—malignant glioma	0.00595	0.00779	CcSEcCtD
Famotidine—Erythema multiforme—Temozolomide—malignant glioma	0.00586	0.00767	CcSEcCtD
Famotidine—Tinnitus—Temozolomide—malignant glioma	0.00578	0.00756	CcSEcCtD
Famotidine—Flushing—Temozolomide—malignant glioma	0.00575	0.00753	CcSEcCtD
Famotidine—Arrhythmia—Carmustine—malignant glioma	0.00573	0.0075	CcSEcCtD
Famotidine—Alopecia—Carmustine—malignant glioma	0.00567	0.00742	CcSEcCtD
Famotidine—HRH2—brain—malignant glioma	0.00562	0.034	CbGeAlD
Famotidine—Mental disorder—Carmustine—malignant glioma	0.00562	0.00735	CcSEcCtD
Famotidine—Alopecia—Temozolomide—malignant glioma	0.00548	0.00717	CcSEcCtD
Famotidine—SLC47A1—central nervous system—malignant glioma	0.00546	0.0331	CbGeAlD
Famotidine—Mental disorder—Temozolomide—malignant glioma	0.00543	0.00711	CcSEcCtD
Famotidine—Back pain—Carmustine—malignant glioma	0.0054	0.00707	CcSEcCtD
Famotidine—SLC47A1—cerebellum—malignant glioma	0.00534	0.0323	CbGeAlD
Famotidine—Dysgeusia—Temozolomide—malignant glioma	0.00528	0.00691	CcSEcCtD
Famotidine—CYP2C19—Diclofenac Metabolic Pathway—CYP2C18—malignant glioma	0.00524	0.0745	CbGpPWpGaD
Famotidine—Back pain—Temozolomide—malignant glioma	0.00522	0.00683	CcSEcCtD
Famotidine—Anaemia—Carmustine—malignant glioma	0.00516	0.00675	CcSEcCtD
Famotidine—Agitation—Carmustine—malignant glioma	0.00513	0.00671	CcSEcCtD
Famotidine—Leukopenia—Carmustine—malignant glioma	0.005	0.00654	CcSEcCtD
Famotidine—Anaemia—Temozolomide—malignant glioma	0.00499	0.00653	CcSEcCtD
Famotidine—Agitation—Temozolomide—malignant glioma	0.00496	0.00649	CcSEcCtD
Famotidine—Angioedema—Temozolomide—malignant glioma	0.00493	0.00645	CcSEcCtD
Famotidine—Convulsion—Carmustine—malignant glioma	0.00484	0.00633	CcSEcCtD
Famotidine—Leukopenia—Temozolomide—malignant glioma	0.00483	0.00632	CcSEcCtD
Famotidine—Palpitations—Temozolomide—malignant glioma	0.00477	0.00624	CcSEcCtD
Famotidine—Chest pain—Carmustine—malignant glioma	0.00475	0.00622	CcSEcCtD
Famotidine—Myalgia—Carmustine—malignant glioma	0.00475	0.00622	CcSEcCtD
Famotidine—Anxiety—Carmustine—malignant glioma	0.00474	0.0062	CcSEcCtD
Famotidine—Cough—Temozolomide—malignant glioma	0.00471	0.00616	CcSEcCtD
Famotidine—Convulsion—Temozolomide—malignant glioma	0.00468	0.00612	CcSEcCtD
Famotidine—Confusional state—Carmustine—malignant glioma	0.00459	0.00601	CcSEcCtD
Famotidine—Arthralgia—Temozolomide—malignant glioma	0.00459	0.00601	CcSEcCtD
Famotidine—Myalgia—Temozolomide—malignant glioma	0.00459	0.00601	CcSEcCtD
Famotidine—Anxiety—Temozolomide—malignant glioma	0.00458	0.00599	CcSEcCtD
Famotidine—Oedema—Carmustine—malignant glioma	0.00456	0.00596	CcSEcCtD
Famotidine—Infection—Carmustine—malignant glioma	0.00453	0.00592	CcSEcCtD
Famotidine—Dry mouth—Temozolomide—malignant glioma	0.00449	0.00588	CcSEcCtD
Famotidine—Thrombocytopenia—Carmustine—malignant glioma	0.00446	0.00584	CcSEcCtD
Famotidine—Confusional state—Temozolomide—malignant glioma	0.00444	0.00581	CcSEcCtD
Famotidine—Oedema—Temozolomide—malignant glioma	0.0044	0.00576	CcSEcCtD
Famotidine—Anaphylactic shock—Temozolomide—malignant glioma	0.0044	0.00576	CcSEcCtD
Famotidine—Infection—Temozolomide—malignant glioma	0.00438	0.00572	CcSEcCtD
Famotidine—Anorexia—Carmustine—malignant glioma	0.00434	0.00568	CcSEcCtD
Famotidine—SLC47A1—brain—malignant glioma	0.00434	0.0262	CbGeAlD
Famotidine—Thrombocytopenia—Temozolomide—malignant glioma	0.00431	0.00564	CcSEcCtD
Famotidine—Anorexia—Temozolomide—malignant glioma	0.0042	0.00549	CcSEcCtD
Famotidine—SLC22A8—central nervous system—malignant glioma	0.00419	0.0254	CbGeAlD
Famotidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00415	0.00543	CcSEcCtD
Famotidine—Insomnia—Carmustine—malignant glioma	0.00412	0.00539	CcSEcCtD
Famotidine—Paraesthesia—Carmustine—malignant glioma	0.00409	0.00535	CcSEcCtD
Famotidine—Somnolence—Carmustine—malignant glioma	0.00405	0.0053	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00401	0.00525	CcSEcCtD
Famotidine—Insomnia—Temozolomide—malignant glioma	0.00398	0.00521	CcSEcCtD
Famotidine—Decreased appetite—Carmustine—malignant glioma	0.00396	0.00518	CcSEcCtD
Famotidine—Paraesthesia—Temozolomide—malignant glioma	0.00395	0.00517	CcSEcCtD
Famotidine—Somnolence—Temozolomide—malignant glioma	0.00392	0.00512	CcSEcCtD
Famotidine—Pain—Carmustine—malignant glioma	0.0039	0.0051	CcSEcCtD
Famotidine—Constipation—Carmustine—malignant glioma	0.0039	0.0051	CcSEcCtD
Famotidine—Dyspepsia—Temozolomide—malignant glioma	0.00388	0.00507	CcSEcCtD
Famotidine—Decreased appetite—Temozolomide—malignant glioma	0.00383	0.00501	CcSEcCtD
Famotidine—Fatigue—Temozolomide—malignant glioma	0.0038	0.00497	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—malignant glioma	0.00379	0.0538	CbGpPWpGaD
Famotidine—Pain—Temozolomide—malignant glioma	0.00377	0.00493	CcSEcCtD
Famotidine—Constipation—Temozolomide—malignant glioma	0.00377	0.00493	CcSEcCtD
Famotidine—Feeling abnormal—Carmustine—malignant glioma	0.00376	0.00491	CcSEcCtD
Famotidine—Gastrointestinal pain—Carmustine—malignant glioma	0.00373	0.00488	CcSEcCtD
Famotidine—Feeling abnormal—Temozolomide—malignant glioma	0.00363	0.00475	CcSEcCtD
Famotidine—Abdominal pain—Carmustine—malignant glioma	0.0036	0.00471	CcSEcCtD
Famotidine—Body temperature increased—Carmustine—malignant glioma	0.0036	0.00471	CcSEcCtD
Famotidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.0036	0.00471	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—malignant glioma	0.00356	0.0506	CbGpPWpGaD
Famotidine—Urticaria—Temozolomide—malignant glioma	0.0035	0.00458	CcSEcCtD
Famotidine—Abdominal pain—Temozolomide—malignant glioma	0.00348	0.00456	CcSEcCtD
Famotidine—Body temperature increased—Temozolomide—malignant glioma	0.00348	0.00456	CcSEcCtD
Famotidine—Hypersensitivity—Carmustine—malignant glioma	0.00336	0.00439	CcSEcCtD
Famotidine—SLC22A8—brain—malignant glioma	0.00333	0.0201	CbGeAlD
Famotidine—Asthenia—Carmustine—malignant glioma	0.00327	0.00428	CcSEcCtD
Famotidine—Hypersensitivity—Temozolomide—malignant glioma	0.00324	0.00425	CcSEcCtD
Famotidine—Asthenia—Temozolomide—malignant glioma	0.00316	0.00413	CcSEcCtD
Famotidine—Diarrhoea—Carmustine—malignant glioma	0.00312	0.00408	CcSEcCtD
Famotidine—Pruritus—Temozolomide—malignant glioma	0.00312	0.00408	CcSEcCtD
Famotidine—Dizziness—Carmustine—malignant glioma	0.00301	0.00394	CcSEcCtD
Famotidine—Diarrhoea—Temozolomide—malignant glioma	0.00301	0.00394	CcSEcCtD
Famotidine—Dizziness—Temozolomide—malignant glioma	0.00291	0.00381	CcSEcCtD
Famotidine—Vomiting—Carmustine—malignant glioma	0.0029	0.00379	CcSEcCtD
Famotidine—Rash—Carmustine—malignant glioma	0.00287	0.00376	CcSEcCtD
Famotidine—Dermatitis—Carmustine—malignant glioma	0.00287	0.00376	CcSEcCtD
Famotidine—Headache—Carmustine—malignant glioma	0.00285	0.00374	CcSEcCtD
Famotidine—Vomiting—Temozolomide—malignant glioma	0.0028	0.00366	CcSEcCtD
Famotidine—Rash—Temozolomide—malignant glioma	0.00278	0.00363	CcSEcCtD
Famotidine—Dermatitis—Temozolomide—malignant glioma	0.00277	0.00363	CcSEcCtD
Famotidine—Headache—Temozolomide—malignant glioma	0.00276	0.00361	CcSEcCtD
Famotidine—Nausea—Carmustine—malignant glioma	0.00271	0.00354	CcSEcCtD
Famotidine—CYP2C19—CYP2E1 reactions—CYP2B6—malignant glioma	0.00269	0.0382	CbGpPWpGaD
Famotidine—Nausea—Temozolomide—malignant glioma	0.00262	0.00342	CcSEcCtD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—POR—malignant glioma	0.00197	0.0279	CbGpPWpGaD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.00178	0.0253	CbGpPWpGaD
Famotidine—CYP2C19—Xenobiotics—CYP2B6—malignant glioma	0.00167	0.0237	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0015	0.0213	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00148	0.021	CbGpPWpGaD
Famotidine—CYP2C19—Xenobiotics—CYP2C18—malignant glioma	0.00145	0.0206	CbGpPWpGaD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A3—malignant glioma	0.00124	0.0176	CbGpPWpGaD
Famotidine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00115	0.0163	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00098	0.0139	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000896	0.0127	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000784	0.0111	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000762	0.0108	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000707	0.01	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000705	0.01	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000696	0.00988	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000693	0.00984	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000684	0.00971	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000671	0.00953	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000601	0.00853	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000593	0.00842	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.000592	0.0084	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000562	0.00798	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000527	0.00748	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.000507	0.0072	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000492	0.00698	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000487	0.00692	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000484	0.00688	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000462	0.00656	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00044	0.00625	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000422	0.006	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.000402	0.00571	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00039	0.00554	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCR4—malignant glioma	0.000386	0.00548	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000377	0.00535	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000369	0.00524	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000369	0.00524	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000359	0.0051	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000358	0.00509	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000345	0.00489	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000341	0.00484	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000332	0.00472	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LATS2—malignant glioma	0.00033	0.00468	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000321	0.00456	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000316	0.00449	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000314	0.00445	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2B6—malignant glioma	0.000298	0.00424	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2B6—malignant glioma	0.000294	0.00418	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000294	0.00417	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000289	0.0041	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCR3—malignant glioma	0.000287	0.00408	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000271	0.00385	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—BDKRB2—malignant glioma	0.000262	0.00373	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—RTEL1—malignant glioma	0.000262	0.00372	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	0.000259	0.00367	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000257	0.00365	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	0.000255	0.00362	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LATS1—malignant glioma	0.00025	0.00355	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00025	0.00355	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—KNG1—malignant glioma	0.000239	0.00339	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000231	0.00328	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BCHE—malignant glioma	0.000221	0.00314	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00022	0.00313	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR4—malignant glioma	0.000218	0.0031	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000209	0.00297	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A3—malignant glioma	0.000208	0.00295	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000203	0.00288	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000202	0.00287	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR4—malignant glioma	0.000198	0.00281	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000196	0.00279	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000184	0.00261	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MDK—malignant glioma	0.000169	0.0024	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000169	0.0024	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCR3—malignant glioma	0.000162	0.0023	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DTX1—malignant glioma	0.000161	0.00229	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000161	0.00228	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000155	0.0022	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—F2—malignant glioma	0.000154	0.00219	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COX8A—malignant glioma	0.00015	0.00214	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—BDKRB2—malignant glioma	0.000148	0.00211	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000147	0.00209	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCR3—malignant glioma	0.000147	0.00209	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000147	0.00208	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000145	0.00206	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000143	0.00203	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000143	0.00203	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—KNG1—malignant glioma	0.000135	0.00192	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—BDKRB2—malignant glioma	0.000135	0.00191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SUFU—malignant glioma	0.000128	0.00182	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ASMT—malignant glioma	0.000128	0.00182	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000128	0.00182	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HEY2—malignant glioma	0.000126	0.0018	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GFAP—malignant glioma	0.000123	0.00175	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000123	0.00175	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000123	0.00175	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KNG1—malignant glioma	0.000123	0.00174	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCAN—malignant glioma	0.00012	0.00171	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SPHK1—malignant glioma	0.000119	0.0017	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000117	0.00167	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HEY1—malignant glioma	0.000117	0.00166	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR4—malignant glioma	0.000117	0.00166	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIST1H3B—malignant glioma	0.000114	0.00161	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BRAF—malignant glioma	0.000113	0.0016	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000112	0.00159	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL8—malignant glioma	0.000109	0.00154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MMP3—malignant glioma	0.000109	0.00154	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000105	0.00149	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JAG2—malignant glioma	0.000104	0.00147	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000101	0.00144	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—IDH2—malignant glioma	9.7e-05	0.00138	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MDM2—malignant glioma	9.46e-05	0.00134	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—RAF1—malignant glioma	9.43e-05	0.00134	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2B6—malignant glioma	9.12e-05	0.0013	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—H3F3A—malignant glioma	8.78e-05	0.00125	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2—malignant glioma	8.72e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCR3—malignant glioma	8.7e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—YWHAE—malignant glioma	8.46e-05	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK2—malignant glioma	8.46e-05	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FLT1—malignant glioma	8.42e-05	0.0012	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COX8A—malignant glioma	8.42e-05	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DUSP6—malignant glioma	8.39e-05	0.00119	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CG—malignant glioma	8.35e-05	0.00119	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—IDH1—malignant glioma	8.34e-05	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JAG1—malignant glioma	8.28e-05	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH3—malignant glioma	8.25e-05	0.00117	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FBXW7—malignant glioma	8.11e-05	0.00115	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SPHK1—malignant glioma	8.07e-05	0.00115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BDKRB2—malignant glioma	7.96e-05	0.00113	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2—malignant glioma	7.92e-05	0.00112	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2C18—malignant glioma	7.91e-05	0.00112	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT2—malignant glioma	7.64e-05	0.00108	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CG—malignant glioma	7.58e-05	0.00108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.53e-05	0.00107	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PTPN11—malignant glioma	7.45e-05	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH2—malignant glioma	7.4e-05	0.00105	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—malignant glioma	7.34e-05	0.00104	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	7.28e-05	0.00103	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KNG1—malignant glioma	7.24e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ASMT—malignant glioma	7.16e-05	0.00102	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7e-05	0.000994	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT2—malignant glioma	6.93e-05	0.000985	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK1—malignant glioma	6.9e-05	0.00098	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCAN—malignant glioma	6.73e-05	0.000956	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—malignant glioma	6.66e-05	0.000946	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP3—malignant glioma	6.41e-05	0.000911	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—malignant glioma	6.4e-05	0.000908	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTT1—malignant glioma	6.39e-05	0.000908	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN2B—malignant glioma	6.36e-05	0.000903	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTK2—malignant glioma	6.17e-05	0.000877	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—malignant glioma	6.15e-05	0.000873	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HES1—malignant glioma	6.06e-05	0.000861	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NCOR1—malignant glioma	6.03e-05	0.000856	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS1—malignant glioma	5.99e-05	0.000851	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAF1—malignant glioma	5.95e-05	0.000845	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IL2—malignant glioma	5.87e-05	0.000834	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—malignant glioma	5.81e-05	0.000825	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDGFRA—malignant glioma	5.77e-05	0.00082	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SPP1—malignant glioma	5.61e-05	0.000796	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—malignant glioma	5.58e-05	0.000793	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCHE—malignant glioma	5.57e-05	0.000791	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC5A5—malignant glioma	5.5e-05	0.000781	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IDH2—malignant glioma	5.43e-05	0.000771	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL2—malignant glioma	5.33e-05	0.000757	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TERT—malignant glioma	5.31e-05	0.000755	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDGFB—malignant glioma	5.19e-05	0.000737	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGFR1—malignant glioma	5.16e-05	0.000733	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.12e-05	0.000727	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2B6—malignant glioma	5.1e-05	0.000725	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIF1A—malignant glioma	5.08e-05	0.000722	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	5.07e-05	0.00072	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—malignant glioma	4.92e-05	0.000698	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—malignant glioma	4.86e-05	0.00069	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2—malignant glioma	4.68e-05	0.000664	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FN1—malignant glioma	4.68e-05	0.000664	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IDH1—malignant glioma	4.67e-05	0.000663	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BAD—malignant glioma	4.62e-05	0.000657	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH1—malignant glioma	4.58e-05	0.00065	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SPHK1—malignant glioma	4.52e-05	0.000641	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CD80—malignant glioma	4.49e-05	0.000637	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—malignant glioma	4.48e-05	0.000636	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—malignant glioma	4.48e-05	0.000636	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—malignant glioma	4.43e-05	0.000629	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGF—malignant glioma	4.43e-05	0.000629	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.42e-05	0.000628	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTPN11—malignant glioma	4.4e-05	0.000625	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAT—malignant glioma	4.31e-05	0.000613	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BRAF—malignant glioma	4.21e-05	0.000598	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.17e-05	0.000593	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT2—malignant glioma	4.1e-05	0.000582	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—malignant glioma	4.08e-05	0.000579	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOR1—malignant glioma	4.07e-05	0.000578	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—malignant glioma	3.94e-05	0.000559	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—malignant glioma	3.9e-05	0.000554	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—malignant glioma	3.85e-05	0.000547	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.8e-05	0.00054	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF2—malignant glioma	3.77e-05	0.000535	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.67e-05	0.000521	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTT1—malignant glioma	3.58e-05	0.000508	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—malignant glioma	3.54e-05	0.000503	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MDM2—malignant glioma	3.53e-05	0.000501	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAF1—malignant glioma	3.51e-05	0.000499	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB2—malignant glioma	3.48e-05	0.000494	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—malignant glioma	3.43e-05	0.000487	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS1—malignant glioma	3.35e-05	0.000476	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.34e-05	0.000475	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—malignant glioma	3.32e-05	0.000472	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—malignant glioma	3.3e-05	0.000468	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—malignant glioma	3.18e-05	0.000452	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—malignant glioma	3.16e-05	0.000448	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL2—malignant glioma	3.15e-05	0.000447	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCHE—malignant glioma	3.12e-05	0.000443	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.08e-05	0.000437	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—malignant glioma	3.02e-05	0.00043	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—malignant glioma	2.98e-05	0.000423	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTEN—malignant glioma	2.96e-05	0.000421	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—malignant glioma	2.92e-05	0.000415	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.91e-05	0.000414	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—malignant glioma	2.89e-05	0.000411	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.89e-05	0.00041	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—malignant glioma	2.68e-05	0.00038	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.66e-05	0.000378	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—malignant glioma	2.65e-05	0.000377	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.52e-05	0.000357	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—malignant glioma	2.48e-05	0.000352	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—malignant glioma	2.46e-05	0.00035	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAT—malignant glioma	2.41e-05	0.000343	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—malignant glioma	2.41e-05	0.000342	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.32e-05	0.000329	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—malignant glioma	2.3e-05	0.000326	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOR1—malignant glioma	2.28e-05	0.000324	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—malignant glioma	2.28e-05	0.000323	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—malignant glioma	2.09e-05	0.000297	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—malignant glioma	2.02e-05	0.000287	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTEN—malignant glioma	2e-05	0.000284	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—malignant glioma	1.86e-05	0.000264	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.78e-05	0.000252	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—malignant glioma	1.71e-05	0.000243	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.69e-05	0.00024	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—malignant glioma	1.63e-05	0.000232	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.49e-05	0.000211	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.41e-05	0.000201	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.3e-05	0.000184	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—malignant glioma	1.29e-05	0.000183	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—malignant glioma	1.15e-05	0.000164	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTEN—malignant glioma	1.12e-05	0.000159	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—malignant glioma	7.91e-06	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—malignant glioma	6.46e-06	9.17e-05	CbGpPWpGaD
